Hyftor
Generic name: Sirolimus
Dosage form: topical gel
Usage of Hyftor
Hyftor is a prescription medicine that is used on the skin (topical) to treat adults and children 6 years of age and older with a type of noncancerous tumor called angiofibroma on your face caused by the genetic condition tuberous sclerosis.
It is not known if this medicine is safe and effective in children under 6 years of age.
Do not use Hyftor if you are allergic to sirolimus or any of the other ingredients. See the end of this page for a complete list of ingredients.
Important: Hyftor is for use on the skin only (topical use). Do not use the gel in your mouth, eyes, or vagina.
Hyftor side effects
Hyftor may cause serious side effects, including:
The most common side effects include dry skin, application site irritation, itching, acne, acne-like rash, eye redness, skin bleeding, and skin irritation. Hyftor may cause fertility problems in males and females, which may affect your ability to have children. Talk to your healthcare provider if this is a concern for you.
These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Hyftor
Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:
How to use Hyftor
Usual Adult Dose for Facial Angiofibroma Associated with Tuberous Sclerosis
- Apply to the skin of the face affected with angiofibroma twice daily. The maximum daily dosage is 800 mg (2.5 cm) for patients 12 years of age and older.
Usual Pediatric Dose for Facial Angiofibroma Associated with Tuberous Sclerosis
-Apply to the skin of the face affected with angiofibroma twice daily. The maximum daily dosage is 600 mg (2 cm) for patients 6 to 11 years of age.
What other drugs will affect Hyftor
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using Hyftor with certain medicines may affect each other causing side effects.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions